obesity. Localized adiposity, Obesity
Conditions
Interventions
Intervention 1: control group: obese patients in the control group receive a placebo daily for 15 weeks similar to sulfate capsule on the intervention group. Intervention 2: intervention group: Obese
Placebo
Treatment - Drugs
control group: obese patients in the control group receive a placebo daily for 15 weeks similar to sulfate capsule on the intervention group
intervention group: Obese individuals in the intervention group received 50 mg of zinc sulfate for 15 weeks.
.
Sponsors
National Nutrition and Food Technology Research Institute
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged 45-18 years; non-smoking; body mass index above 30 kg/m2 Exclusion criteria: pregnancy; lactation; menopause in women; a history of liver disease; kidney disease; thyroid; diabetes and other metabolic diseases; drugs interfering with lipid profile; blood-thinning drugs; beta-blockers; patients with immune deficiency; zinc supplementation; calcium and iron in 2 months; use of weight loss drugs or diet; weight loss diet in the last 2 months; recent surgery
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Serum TNF-alpha concentration. Timepoint: before intervention,fifteen weeks after intervention. Method of measurement: Enzymatic method by kit.;Hs-CRP concentration. Timepoint: before intervention,fifteen weeks after intervention. Method of measurement: Enzymatic method by kit.;Apelin concentration. Timepoint: before intervention,fifteen weeks after intervention. Method of measurement: Enzymatic method by kit. | — |
Primary
| Measure | Time frame |
|---|---|
| Body mass Index. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: calculating.;Weight. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: Seca scale.;Waist circumference. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: meter.;Hip circumference. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: meter.;Waist circumference to hip ratio. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: calculating.;Body fat percentage. Timepoint: before intervention, seven weeks after intervention,fifteen weeks after intervention. Method of measurement: Bioelectrical Impedance Analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHoda Khorsandi
National Nutrition and Food Technology Research Institute
Outcome results
None listed